Neuroprotection in CNS demyelinating disease by SIRT1 activators: A potential oral therapy

被引:0
|
作者
Shindler, Kenneth S.
Ventura, Elvira
Elliott, Peter
Rostami, A. M.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S75 / S75
页数:1
相关论文
共 50 条
  • [41] Discovery and characterization of a new class of NAD plus -independent SIRT1 activators
    Della Torre, Sara
    Dell'Omo, Giulia
    Dellavedova, Jessica
    Palazzolo, Luca
    Scanziani, Eugenio
    Eberini, Ivano
    Pinto, Andrea
    Mitro, Nico
    Conti, Paola
    Villa, Alessandro
    Ciana, Paolo
    PHARMACOLOGICAL RESEARCH, 2024, 206
  • [42] Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
    Milne, Jill C.
    Lambert, Philip D.
    Schenk, Simon
    Carney, David P.
    Smith, Jesse J.
    Gagne, David J.
    Jin, Lei
    Boss, Olivier
    Perni, Robert B.
    Vu, Chi B.
    Bemis, Jean E.
    Xie, Roger
    Disch, Jeremy S.
    Ng, Pui Yee
    Nunes, Joseph J.
    Lynch, Amy V.
    Yang, Hongying
    Galonek, Heidi
    Israelian, Kristine
    Choy, Wendy
    Iffland, Andre
    Lavu, Siva
    Medvedik, Oliver
    Sinclair, David A.
    Olefsky, Jerrold M.
    Jirousek, Michael R.
    Elliott, Peter J.
    Westphal, Christoph H.
    NATURE, 2007, 450 (7170) : 712 - 716
  • [43] 2-Aryl-benzimidazole-4-carboxamides as novel SIRT1 activators
    Disch, Jeremy S.
    Vu, Chi B.
    McPherson, Lauren
    Ng, Pui Yee
    Bemis, Jean E.
    Carney, David P.
    Lynch, Amy V.
    Loh, Christine
    Ribich, Scott
    Romero, Peggy
    Smith, Jesse J.
    Song, Jeffrey
    Gagne, David J.
    Cote, Angela
    Davis, Meghan
    Lainez, Elden
    Perni, Robert B.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [44] Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
    Jill C. Milne
    Philip D. Lambert
    Simon Schenk
    David P. Carney
    Jesse J. Smith
    David J. Gagne
    Lei Jin
    Olivier Boss
    Robert B. Perni
    Chi B. Vu
    Jean E. Bemis
    Roger Xie
    Jeremy S. Disch
    Pui Yee Ng
    Joseph J. Nunes
    Amy V. Lynch
    Hongying Yang
    Heidi Galonek
    Kristine Israelian
    Wendy Choy
    Andre Iffland
    Siva Lavu
    Oliver Medvedik
    David A. Sinclair
    Jerrold M. Olefsky
    Michael R. Jirousek
    Peter J. Elliott
    Christoph H. Westphal
    Nature, 2007, 450 : 712 - 716
  • [45] Design, Synthesis and Pharmacological Evaluation of Naphthofuran Derivatives as Potent SIRT1 Activators
    Gao, Jian
    Chen, Qing-Qing
    Huang, Ye
    Li, Kai-Hang
    Geng, Xiao-Ju
    Wang, Tao
    Lin, Qi-Si
    Yao, Ruo-Si
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [46] SIRT1 silencing confers neuroprotection through IGF-1 pathway activation
    Sansone, Luigi
    Reali, Valentina
    Pellegrini, Laura
    Villanova, Lidia
    Aventaggiato, Michele
    Marfe, Gabriella
    Rosa, Roberta
    Nebbioso, Marcella
    Tafani, Marco
    Fini, Massimo
    Russo, Matteo A.
    Pucci, Bruna
    JOURNAL OF CELLULAR PHYSIOLOGY, 2013, 228 (08) : 1754 - 1761
  • [47] The role of SIRT1 in diabetic kidney disease
    Yacoub, Rabi
    Lee, Kyung
    He, John Cijiang
    FRONTIERS IN ENDOCRINOLOGY, 2014, 5
  • [48] Small molecule activators of SIRT1 augment the regenerative potential of chondrocytes for cell-based cartilage repair techniques
    Heywood, H. K.
    Thorpe, S. D.
    Jeropoulos, R. M.
    Lee, D. A.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2017, 98 (06) : A14 - A14
  • [49] Discovery of Imidazo[1,2-b]thiazole Derivatives as Novel SIRT1 Activators
    Vu, Chi B.
    Bemis, Jean E.
    Disch, Jeremy S.
    Ng, Pui Yee
    Nunes, Joseph J.
    Milne, Jill C.
    Carney, David P.
    Lynch, Amy V.
    Smith, Jesse J.
    Lavu, Siva
    Lambert, Philip D.
    Gagne, David J.
    Jirousek, Michael R.
    Schenk, Simon
    Olefsky, Jerrold M.
    Perni, Robert B.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (05) : 1275 - 1283